ST AIA-PACK PA

Total, Prostate Specific Antigen (noncomplexed & Complexed) For Detection Of Prostate Cancer

FDA Premarket Approval P910065 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for adding the assay of tosoh st aia-pack. Psa (prostate specific antigen) to the tosoh a1a-2000 st/la instrument, and extension of the calibration curvestability for the st aia-pack pa psa assay from 60 days to 90 days for aia nex. Ia, aia-600 ii, aia-360, aia-1800, and aia-2000.

DeviceST AIA-PACK PA
Classification NameTotal, Prostate Specific Antigen (noncomplexed & Complexed) For Detection Of Prostate Cancer
Generic NameTotal, Prostate Specific Antigen (noncomplexed & Complexed) For Detection Of Prostate Cancer
ApplicantTOSOH BIOSCIENCE, INC.
Date Received2009-04-24
Decision Date2009-11-30
PMAP910065
SupplementS007
Product CodeMTF
Advisory CommitteeImmunology
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address TOSOH BIOSCIENCE, INC. 6000 Shoreline Court suite 101 south San Francisco, CA 94080

Supplemental Filings

Supplement NumberDateSupplement Type
P910065Original Filing
S009 2019-05-20 Special (immediate Track)
S008 2011-03-30 Normal 180 Day Track
S007 2009-04-24 Normal 180 Day Track
S006 2005-06-06 Normal 180 Day Track
S005 2004-04-07 Normal 180 Day Track
S004 2003-06-04 Normal 180 Day Track
S003 2002-01-09 Normal 180 Day Track
S002 1999-12-16 Normal 180 Day Track
S001 1999-03-25 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.